Medeon Biodesign Inc Share Price Taipei Exchange
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- | - |
05-10 | Medeon Biodesign, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-08 | Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 298M 9.28M 0 730M | Sales 2023 | 196M 6.1M 0 480M | Capitalization | 4.29B 133M 0 10.5B |
---|---|---|---|---|---|
Net income 2022 | -434M -13.49M - -1.06B | Net income 2023 | -1.2B -37.47M - -2.95B | EV / Sales 2022 | 12.5 x |
Net cash position 2022 | 1.35B 41.92M 0 3.3B | Net cash position 2023 | 1.96B 60.79M 0 4.78B | EV / Sales 2023 | 11.9 x |
P/E ratio 2022 |
-11.7
x | P/E ratio 2023 |
-3.56
x | Employees | - |
Yield 2022 |
0.86% | Yield 2023 |
-
| Free-Float | 47.57% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Te Chang
CEO | Chief Executive Officer | - | 21/12/12 |
Ching Yi Chen
DFI | Director of Finance/CFO | - | - |
Greta Chang
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yu Te Chang
CEO | Chief Executive Officer | - | 21/12/12 |
Chih Lung Shen
BRD | Director/Board Member | 59 | 19/04/15 |
Hong Jen Chang
BRD | Director/Board Member | 68 | 13/01/14 |
1st Jan change | Capi. | |
---|---|---|
+12.15% | 228B | |
+14.90% | 196B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 65.88B | |
+16.92% | 54.3B | |
+6.33% | 52.39B | |
+10.93% | 45.22B | |
+5.87% | 37.12B |